Committed to excellence in pharmaceutical distribution and healthcare solutions.
Ascend Laboratories (Pty) Ltd operates as a wholly-owned subsidiary of Alkem Laboratories Limited. Alkem is a global pharmaceutical powerhouse, bringing years of formulation development and regulatory expertise to the South African market.
"South African arm of Alkem Laboratories Ltd. — a company with a 50-year legacy of healthcare innovation."
We have committed significant resources toward securing SAHPRA registrations and establishing solid distribution linkages. Our vision is to offer patients and medical providers a comprehensive range of therapeutics, ensuring that critical care is both affordable and accessible.
Since our establishment, Ascend Laboratories has steadily grown its SAHPRA-registered portfolio and distribution footprint, building a trusted reputation for quality and reliability in the South African pharmaceutical market.
"Every regulatory milestone represents our commitment to making high-quality generic medicines accessible to all South Africans."
2013
Foundation & First SAHPRA Registrations
Ascend Laboratories (Pty) Ltd established as a wholly-owned subsidiary of Alkem Laboratories Limited. First wave of SAHPRA product registrations secured for Alkoxime and Mycokem ranges.
2014
First Commercial Product Launches
Mycokem 500 and Mycokem 250 commercially launched into South African healthcare market. Cefuroxime-based Alkoxime range reaches hospital procurement networks.
2021
CNS & Specialty Portfolio Expansion
Successful market entry for Linezolid and Cefalexin products. Ascend expands its specialty pharmaceutical offering into CNS and anti-infective therapeutic areas.
2022–2024
CNS, Immunology & Metabolic Launches
Olanzapine, Rasagiline, Quetiapine, and Mycophenolate sodium products commercially launched. Distribution partnerships broadened across public and private sector.
2025–2026
Strategic Portfolio Growth
Launch of Dapagliflozin, Gabapentin, Vortioxetine, Solifenacin, Cholestyramine, Zolpidem, and Tamsulosin — cementing Ascend as a multi-therapeutic generic leader in South Africa.
At Ascend, we are dedicated to offering a comprehensive range of high-quality prescription and over-the-counter (OTC) medicines. Our product portfolio spans a broad spectrum of therapeutic areas, ensuring that we meet the diverse needs of patients and healthcare providers across South Africa.
In addition to our extensive range of generic medicines, we are also engaged in securing robust supply chains and regulatory compliance. Our expertise in managing these sensitive and critical products ensures they are delivered with the utmost care and compliance with international regulatory standards.
The commitments that drive our operations every day
We are committed to providing medicines that meet rigorous quality standards, ensuring safety and efficacy.
Our focus on cost efficiency helps us offer essential therapeutic remedies at highly accessible pricing.
Reliability in supply is crucial for healthcare delivery. We ensure robust and dependable distribution channels.
Our ultimate goal is supporting patient health and well-being through high-value pharmaceutical care.
As a subsidiary of Alkem Laboratories, Ascend benefits from a legacy of global excellence and a vast reservoir of expertise. Our South African operations are complemented by global resources, ensuring that we deliver innovative solutions that are both locally relevant and globally impactful.
We are proud of our ability to balance cost efficiency with quality assurance, ensuring that we deliver reliable and effective products to our partners and customers. Our commitment to regulatory compliance and ethical practices underscores our dedication to the highest standards.
Join hundreds of healthcare providers who trust Ascend Laboratories for quality generic medicines.